We extend our heartfelt gratitude to all our partners for your unwavering support in making Biologics Manufacturing Korea 2025 co-located with CGT East Asia 2025 and ADC & Bioconjugate East Asia 2025 an outstanding success! We are excited to present this post-conference report, which highlights the key achievements and insights from this year’s event and helps you assess the ROI of your participation.

Held on 25 and 26 September 2025, the conferences ran concurrently and also featured a site tour of Prestige Biologics and a pre-conference workshop by MasterControl. Once again, we had the privilege of hosting world-renowned speakers, industry experts, and leaders from across Asia Pacific. They shared their deep expertise across the rapidly advancing fields of biologics manufacturing, next generation cell and gene therapies, and cutting edge ADC and bioconjugate development.

Participants gained strategic insights through high level discussions, forward looking case studies, and meaningful peer to peer networking, all centered on the transformative trends, technological breakthroughs, and growth opportunities shaping the future of advanced therapies and biomanufacturing within the South Korean landscape.

The enthusiastic feedback we received reaffirmed the event’s relevance, its balanced focus across the industry, and its value in fostering impactful connections that drive continued progress.

As we reflect on this year’s success, we are thrilled to incorporate your suggestions to make the 2026 edition even bigger and better. We look forward to welcoming you back on 16-17 September 2026 as we continue to elevate this premier platform for biologics manufacturing leaders across the region.

Once again, thank you for your continued partnership and for contributing to the growth and success of our industry!